Sheng CC, Sahoo D, Dugar S, Prada RA, et al. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol 2020;43:1055-1063.
PMID: 32830894